Chan Monica, Lye David, Win Mar Kyaw, Chow Angela, Barkham Tim
Department of Infectious Diseases, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 308433, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 308433, Singapore.
Int J Infect Dis. 2014 Sep;26:110-5. doi: 10.1016/j.ijid.2014.05.019. Epub 2014 Jul 11.
To describe the clinical features, treatments, outcomes, and subtype prevalence of cryptococcosis in Singapore.
All patients with laboratory confirmed cryptococcal infections admitted from 1999 to 2007 to a teaching hospital in Singapore were reviewed retrospectively. Identification and molecular types of Cryptococcus neoformans variants and Cryptococcus gattii were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Serotypes were inferred with a multiplex PCR method.
Of 62 patients with cryptococcosis, C. neoformans var. grubii was the predominant subtype (in 95%), affecting mainly immunocompromised hosts (91%) with HIV infection (80%). Patients with HIV were younger (median age 36.5 vs. 49.5 years, p=0.006) and less likely to present with an altered mental status (14% vs. 50%, p=0.013). In contrast, delayed treatment (median 7 days vs. 2 days, p=0.03), pulmonary involvement (58% vs. 14%, p=0.03), and initial treatment with fluconazole (25% vs. 2%, p=0.02) were more common in HIV-negative patients. C. gattii was uncommon, affecting only three patients, all of whom were immunocompetent and had disseminated disease with pulmonary and neurological involvement. All C. gattii were RFLP type VG II, serotype B and all C. neoformans var. grubii were RFLP type VN I, serotype A, except for one that was RFLP type VN II.
C. neoformans var. grubii, subtype VN I, was the predominant subtype in Singapore, infecting younger, mainly immunocompromised hosts with HIV. C. gattii was uncommon, causing pulmonary manifestations in older, immunocompetent patients and were RFLP type VG II.
描述新加坡隐球菌病的临床特征、治疗方法、预后及亚型流行情况。
回顾性分析1999年至2007年入住新加坡一家教学医院且实验室确诊为隐球菌感染的所有患者。通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)确定新型隐球菌变种和格特隐球菌的鉴定及分子类型。用多重PCR方法推断血清型。
62例隐球菌病患者中,新型隐球菌格鲁比变种是主要亚型(95%),主要影响免疫功能低下宿主(91%),其中HIV感染患者占80%。HIV患者更年轻(中位年龄36.5岁对49.5岁,p=0.006),出现精神状态改变的可能性更小(14%对50%,p=0.013)。相比之下,HIV阴性患者延迟治疗更常见(中位7天对2天,p=0.03)、肺部受累更常见(58%对14%,p=0.03)以及初始使用氟康唑治疗更常见(25%对2%,p=0.02)。格特隐球菌不常见,仅累及3例患者,所有患者免疫功能正常,有播散性疾病,累及肺部和神经系统。所有格特隐球菌均为RFLP VG II型、血清型B,所有新型隐球菌格鲁比变种均为RFLP VN I型、血清型A,但有1例为RFLP VN II型。
新型隐球菌格鲁比变种,亚型VN I,是新加坡的主要亚型,感染年轻的、主要是免疫功能低下的HIV宿主。格特隐球菌不常见,在年龄较大、免疫功能正常的患者中引起肺部表现,且为RFLP VG II型。